Trading ban on Jamjoom Pharma’s major shareholders ends today

19/12/2023 Argaam
Logo ofJamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)

Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)


The ban on Jamjoom Pharmaceuticals Factory Co.’s (Jamjoom Pharma) major shareholders from selling shares was lifted today, Dec. 19, six months after the stock began trading on the Saudi Exchange (Tadawul) on June 20. 

 

Major shareholders, who own 70% of the company’s capital, were subject to a six-month ban, starting from the stock debut on Tadawul. 

 

As of today, they will be able to sell their shares without prior approval from the Capital Market Authority (CMA).

 

Company Shareholders

Shareholders

 

Post-IPO

Number of Shares

(mln)

Ownership
(%)

Yousuf Mohammed Saleh Jamjoom

29.16

41.65%

Mahmoud Yousuf Mohammed Saleh Jamjoom 

3.92

5.60%

Walid Yousuf Mohammed Saleh Jamjoom 

3.185

4.55%

Sanaa Yousuf Mohammed Saleh Jamjoom 

3.185

4.55%

Mohammed Yousuf Mohammed Saleh Jamjoom

3.185

4.55%

Ahmed Yousuf Mohammed Saleh Jamjoom 

3.185

4.55%

Alaa Yousuf Mohammed Saleh Jamjoom 

3.185

4.55%

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.